Skip to content

Precise selection of endarterectomy or stent intervention based on quantitative assessment of carotid atheromatous plaque stability

Precise selection of endarterectomy or stent intervention based on quantitative assessment of carotid atheromatous plaque stability

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069055
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-03-13
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis

Interventions

Group of Carotid Artery Stenosis:None

Sponsors

Changhai hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Is able to provide written consent form; 2.Age 18-85 years; 3.No history of radiation therapy; 4.No previous percutaneous treatment including balloon and stent angioplasty, and CEA on the target side; 5.CAS or CEA will be performed on the target side accoding to the best experience of the medical team in charge.

Exclusion criteria

Exclusion criteria: 1.Induced by cardiogenic thrombosis, or atherosclerotic diseases located in the aortic arch, or intracranial circulations; 2.Co-existance of aneurysm in the head and neck; 3.Luminal stenosis=50% in the intracranial segment of internal carotid artery, vertebrobasilar artery, or middle cerebral artery; 4.History of radiation therapy and ipsilateral CEA or CAS; 5.Not suitable for MR imaging, e.g., patients suffered from claustrophobia, with MR non-compatible metal implantation, such as aneurysm clip, cochlear implant, allergy to MR contrast agent; 6.MR compatible metal implantation near the target region; 7.Pregnant patients; 8.Patients with conditions unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
death due to stroke;disabling stroke;transient ischemic attack;all causes of death;plaque drop out;withdrawal;lost of follow-up;

Secondary

MeasureTime frame
Other major adversed cardiovascular events;

Countries

China

Contacts

Public Contactzhiqing zhao

Shanghai Changhai Hospital

zhaozqxueguan@126.com+86 13301617866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026